Critical Pharmaceuticals
Nottingham · Founded 2002
About Critical Pharmaceuticals
Critical Pharmaceuticals is a biotechnology company with proprietary drug delivery technologies for the sustained release and nasal delivery of proteins and peptides and labile or insoluble small molecules. Critical Pharmaceuticals was founded by Professor Steve Howdle in 2002 based on his research into supercritical fluids. When gases reach a certain temperature and pressure (the critical point) they become "supercritical" and take on both gas and liquid like properties. He noticed that supercritical carbon dioxide (scCO2) was able to penetrate certain polymers, and in a moment of inspiration realised that this could be used to mix thermally labile or solvent sensitive substances into the polymers.
Company Facts
- Founded: 2002
- Legal name: Critical Pharmaceuticals Limited
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $3.7M
- Funding stage: Late Stage Venture
- Last round: Grant (Jan 2015)
- Website: criticalpharmaceuticals.com
- Phone: 44-(0)115-8820-100
Social Profiles
Canonical: https://fsome.com/organization/critical-pharmaceuticals-8385997 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.